The anti-tumor activity of CDK2 inhibition alone or in combination with other anti-cancer agents in human cancers

被引：0
|
作者：
Chen, Yaoyu
Chen, Jinhong
Guo, Yali
Pang, Wei
Zhou, Tingru
Liu, Xipan
Schomer, Nathan
Li, Fang
Liang, Jiaqi
Sheng, Qing
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-B173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B173
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
    Liu, Hongyu
    Zang, Chuanbing
    Emde, Anna
    Planas-Silva, Maricarmen D.
    Rosche, Marleen
    Kuehnl, Andrea
    Schulz, Carsten-Oliver
    Elstner, Elena
    Possinger, Kurt
    Eucker, Jan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 591 (1-3) : 43 - 51
  • [2] Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials
    Chris H. Takimoto
    Ahmad Awada
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 535 - 548
  • [3] Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents:: a review of clinical trials
    Takimoto, Chris H.
    Awada, Ahmad
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 535 - 548
  • [4] Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents
    Ma, Ying-Yu
    Mou, Xiao-Zhou
    Ding, Ya-Hui
    Zou, Hai
    Huang, Dong-Sheng
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (10) : 1397 - 1406
  • [5] ANTI-CANCER AGENTS .13. SYNTHESIS AND ANTI-TUMOR ACTIVITY OF 2-IMINOCHROMENE DERIVATIVES
    OCALLAGHAN, CN
    CONALTY, ML
    PROCEEDINGS OF THE ROYAL IRISH ACADEMY SECTION B-BIOLOGICAL GEOLOGICAL AND CHEMICAL SCIENCE, 1979, 79 (06) : 87 - 98
  • [6] In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
    Gravett, Andrew M.
    Liu, Wai M.
    Krishna, Sanjeev
    Chan, Wing-Chi
    Haynes, Richard K.
    Wilson, Natalie L.
    Dalgleish, Angus G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 569 - 577
  • [7] In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents
    Andrew M. Gravett
    Wai M. Liu
    Sanjeev Krishna
    Wing-Chi Chan
    Richard K. Haynes
    Natalie L. Wilson
    Angus G. Dalgleish
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 569 - 577
  • [8] Anti-tumor effects of fadraciclib, CDK2/9 inhibitor, in biliary tract cancer
    Kim, Jae-Min
    Nam, Ah-Rong
    Oh, Kyoung-Seok
    Bang, Ju-Hee
    Jeong, Yoojin
    Choo, Sea Young
    Lee, Su In
    Kim, Hyo Jung
    Yoon, Jeesun
    Kim, Tae-Yong
    Oh, Do-Youn
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health
    Niamah, Alaa Kareem
    Al-Sahlany, Shayma Thyab Gddoa
    Verma, Deepak Kumar
    Shukla, Rakesh Mohan
    Patel, Ami R.
    Tripathy, Soubhagya
    Singh, Smita
    Baranwal, Deepika
    Singh, Amit Kumar
    Utama, Gemilang Lara
    Gonzalez, Monica L. Chavez
    Alhilfi, Wissal Audah Hassan
    Srivastav, Prem Prakash
    Aguilar, Cristobal Noe.
    HELIYON, 2024, 10 (17)
  • [10] BMS-387032: A selective CDK2 inhibitor with potent anti-tumor activity.
    Misra, RN
    Xiao, HY
    Kim, KS
    Lu, SF
    Han, WC
    Rawlins, DB
    Shan, WF
    Ahmed, SZ
    Qian, L
    Chen, BC
    Zhao, RL
    Bednarz, MS
    Bursuker, I
    Kellar, KA
    Mulheron, JG
    Batorsky, R
    Roongta, U
    Sacks, JS
    Tokarski, JS
    Lee, FY
    Bol, DK
    Kamath, A
    Humphreys, WG
    Marathe, P
    Hunt, JT
    Pavletich, NP
    Kimball, SD
    Webster, KR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U176 - U176
12345